. The development of sitespecific nucleases, such as zinc finger nucleases, has greatly facilitated functional studies in cells due to the fact that both copies of a gene can be efficiently inactivated in a single step 3 . Recently, the CRISPR-Cas9 gene editing technology [4] [5] [6] [7] has become the tool of choice for gene knockout studies due to its simplicity and robustness. Cas9 nuclease is an RNA-guided nuclease that is highly efficient in inducing a double-strand break (DSB) at a genomic site of interest. These DSBs can be repaired by error-prone non-homologous end joining (NHEJ) to generate gene-inactivating mutations or, in the presence of a donor template, the DSBs can be repaired by homology-directed repair (HDR) to generate more precise and complex alleles 8 . While simple constitutive knockouts are useful and informative, in many cases it is desirable to engineer conditional loss-of-function models, particularly
for genes essential for cell viability or embryonic development. Here, we describe a simplified, onestep method for engineering conditional loss-of-function mutations in diploid cells. We developed a novel, invertible drug selection cassette, FLIP, for high-efficiency nuclease-assisted targeting in cells.
We are able to recover biallelic events from a single round of gene targeting and screening. As proof-of-principle, we applied our method to conditionally inactivate both essential and nonessential genes in mouse and human cells.
Existing methods for engineering conditional mutations in cultured cells [9] [10] [11] [12] rely on the inclusion of a drug selection cassette that must be removed in a second step to ensure proper expression of targeted conditional allele (see Supplementary Fig 1) . These methods were not designed for the generation of conditional loss-of-function models in a single step, particularly where the target gene is essential for cell growth or viability. To overcome these limitations, our strategy combines an invertible intronic cassette (FLIP), similar to COIN
12
, with high efficiency Cas9-assisted gene editing.
Critically, the non-mutagenic orientation of the FLIP cassette expresses the puromycin resistance gene (puroR) to select for correct nuclease-assisted targeting into the exon of one allele and simultaneous enrichment of cells that inactivate the second allele by nuclease-mediated NHEJ (Fig   1a) . Upon exposure to Cre recombinase the FLIP cassette is inverted to a mutagenic configuration that activates a cryptic splice acceptor and polyadenylation signal (pA) and disrupting the initial splicing acceptor resulting in the complete loss of gene function ( Fig. 1b and Supplementary Fig. 2a ).
In contrast to COIN which requires the removal of the drug selection cassette, our FLIP cassette permits the generation of conditional mutant cells in one step.
Initially, to test the functionality of our intronic FLIP cassette, we inserted a FLIP cassette variant containing a dsRed2 reporter in place of puroR into a CMV-eGFP (enhanced green fluorescent protein) expression plasmid (Fig. 1c) . Following transient transfection of HEK293 cells, both green and red fluorescence was observed, demonstrating that insertion of the FLIP cassette in the nonmutagenic orientation is inert (Fig. 1d) . Cre recombinase-mediated FLIP cassette inversion resulted in loss of eGFP expression, showing conditional inactivation of eGFP expression in the inverted, mutagenic orientation (Fig. 1c,d ).
Next, we employed CRISPR/Cas9 endonuclease in mouse embryonic stem cells (mESCs) to introduce the puroR FLIP cassette into one allele of β-catenin (Ctnnb1) via HDR and to simultaneously induce a frameshift mutation by NHEJ in the second β-catenin allele (Fig. 1a, 2a ). β-catenin is an important gene for the morphology and efficient self-renewal of mESCs 13, 14 . A donor vector containing the puroR FLIP cassette inserted in exon 5 of β-catenin and flanked by ~1 kb homology arms was transfected into mESCs with Cas9 and gRNA expression plasmids. Following selection in puromycin, drug-resistant colonies were genotyped by PCR to confirm correct integration of the FLIP cassette and then assayed for NHEJ events in the second allele by Sanger sequencing (Fig. 2b ,c, Supplementary Fig. 2b ). From 64 clones, 14 clones (21.9%) were correctly targeted, among which 4
clones carried a frame-shift mutation in the second allele ( Table 1 (Table 1) . For all genes, FLIP/-clones were obtained (Table 1 , Supplementary Fig. 4-7) . The conditional inactivation of gene expression was confirmed by Western blot and immunofluorescence for Esrrb and Sox2 ( Supplementary Fig. 4 ). We conclude that the FLIP conditional strategy is efficient and can be applied widely for conditional loss-of-function studies in various mammalian cells that are amenable to Cas9-assisted gene targeting.
Our strategy requires the presence of a CRISPR site overlapping or nearby the insertion site of the FLIP cassette, imposing constraints on the exons than can be targeted. To maximize the potential for a null mutation, the target exon must be common to all transcripts and lie within the first 50% of the protein-coding sequence. Additionally, based on the minimum size of mammalian exons (50 bp)
we set the size of the split exons to be at least 60 bp. Finally, for optimal splicing, we chose insertion points that match the consensus sequence for mammalian splice junctions (minimally MAGR ( A / C AG/Pu)) 16 . 
Methods

dsRed FLIP cassette inserted in the eGFP cDNA
The FLIP cassette inserted in the middle of eGFP and containing a dsRed2 reporter gene was synthesized and ordered from GenScript. The split eGFP cDNA and the FLIP cassette were cloned into the mammalian expression vector pCDNA4TO (Invitrogen) using BamHI (R0136S, NEB) and XhoI (R0146S, NEB) (for pre-recombined form). The vector was subsequently transformed into Cre expressing bacteria (A111, Gene bridges) to generate the Cre-recombined form. Correct clones were confirmed with restriction digest BamHI (R0136S, NEB) and XhoI (R0146S, NEB) and Sanger sequencing.
FLIP cassette containing selection marker genes
The FLIP cassette was PCR amplified and cloned into Pjet1.2 vector (ThermoFisher Scientific, K131).
Replacement of dsRed was done through restriction digest excision using EcoRI (R3101S, NEB) and Acc65l (RO599S, NEB) followed by insertion of PCR amplified selection marker genes using Infusion cloning (638909, Clontech). The FLIP cassette including selection marker gene was then transferred to the vector pUC118 (3318, Clontech) using the restriction enzymes SacI (R0156S, NEB) and PstI (R0140S, NEB) and Mighty cloning (6027, Takara).
Addition of homologous arms to the FLIP cassette -FLIP targeting vector generation
Homologous arms around an intron insertion site were amplified by high fidelity Phusion DNA polymerase (M0530S, NEB). After PCR product purification, both homologous arms and FLIP cassette-containing vector were mixed with the type II restriction enzyme SapI and T4 DNA ligase (M0202T, NEB). After 25 cycles of 37°C and 16°C, the reaction mixture was directly used for E.Coli transformation. DNA was extracted (27106, Qiagen) and analysed with restriction digest to identify correctly assembled FLIP donor vectors.
Cas9 and gRNA plasmids
Human codon optimized Cas9 (41815, Addgene) and empty gRNA vector (41824, Addgene) were obtained from Addgene. 
